Back
MoonLake Immunotherapeutics 10K Form
Buy
71
MLTX
MoonLake Immunotherapeutics
Last Price:
52.02
Seasonality Move:
36.4%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive MLTX News And Ratings
See the #1 stock for the next 7 days that we like better than MLTX
MLTX Financial Statistics
Sales & Book Value
| Annual Sales: | -- |
|---|---|
| Cash Flow: | $-25.41M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $7.74 |
| Price / Book: | 6.7 |
Profitability
| EPS (TTM): | -1.27000 |
|---|---|
| Net Income (TTM): | $-80.77M |
| Gross Margin: | -- |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
MoonLake Immunotherapeutics Earnings Forecast
Key MoonLake Immunotherapeutics Financial Ratios
- Per Share Earnings over the last 3 years have been positive in 1 years.
MoonLake Immunotherapeutics Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | MLTX |
| Website: | moonlaketx.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
MLTX Technical Analysis vs Fundamental Analysis
Buy
71
MoonLake Immunotherapeutics (MLTX)
is a Buy
Is MoonLake Immunotherapeutics a Buy or a Sell?
-
MoonLake Immunotherapeutics stock is rated a Buy
The current MoonLake Immunotherapeutics [MLTX] share price is $51.86. The Score for MLTX is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.